Do patients with heart failure benefit from coronary artery bypass grafting?
The purpose of this review is to examine the appropriateness of coronary artery bypass grafting (CABG) for the patient with ischemic cardiomyopathy and congestive heart failure. CABG is the gold standard therapy for patients with advanced multivessel and left main coronary artery disease. A critical analysis of the Surgical Treatment of Ischemic Heart Failure (STICH) trial confirms the benefit of CABG for patients with ischemic cardiomyopathy. CABG can be safely applied to patients with heart failure and provides benefit for appropriately selected patients.